LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Giα dependent PI-3kinase signalling
Tóm tắt
COPD is a disease of innate immunity and bacterial infections are a dominant cause of exacerbations in the later stages resulting in poor health and high mortality. The pathogen-associated molecular pattern (PAMP) lipopolysaccharide (LPS) is sensed by immune cells through activation of the toll-like receptor 4 (TLR4). This leads to the activation of NADPH oxidase (NOX) and NF-κB which together drive COPD inflammation. In this study we show in human PBMCs that LPS stimulated proinflammatory cytokine release (CXCL8 and IL6) was inhibited by approximately 50% by the broad specificity phosphatidylinositol 3-kinase (PI3K) inhibitor, wortmannin. Our results also demonstrate that activation of PI3K following LPS stimulation is mediated by a NOX4 dependent mechanism releasing endogenous H2O2, as the NOX4 inhibitor apocynin blocked LPS induced AKT phosphorylation. Moreover, LPS-induced PI3K activation was inhibited by the anti-oxidant N-acetylcysteine in a concentration dependent manner (IC50 ~100 μM). In addition, our data demonstrated that inhibition of small G proteins, by pre-treatment with pertussis toxin, inhibited LPS-induced AKT phosphorylation. Furthermore, the G-protein inhibitors pertussis toxin and mastoparan both inhibited LPS-induced CXCL8 and IL-6 release by approximately 50%. Together, these data indicate there is a mechanism in human PBMCs where TLR4 activation by LPS leads to ROS generation through NOX4 and activation of the PI3K pathway. This effect is apparently mediated through small G proteins facilitating the release of pro-inflammatory cytokines.
Tài liệu tham khảo
Sweet MJ, Hume DA: Endotoxin signal transduction in macrophages. J Leukoc Biol. 1996, 60 (1): 8-26.
Akira S: Toll-like receptor signaling. J Biol Chem. 2003, 278 (40): 38105-8. 10.1074/jbc.R300028200.
Wright SD: Toll, a new piece in the puzzle of innate immunity. J Exp Med. 1999, 189 (4): 605-9. 10.1084/jem.189.4.605.
Poltorak A, et al.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998, 282 (5396): 2085-8.
Qureshi ST, et al.: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med. 1999, 189 (4): 615-25. 10.1084/jem.189.4.615.
Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001, 2 (8): 675-80. 10.1038/90609.
Park HS, et al.: Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa. B J Immunol. 2004, 173 (6): 3589-93.
Gutteridge JM, Halliwell B: Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci. 2000, 899: 136-47.
Rahman I, Adcock IM: Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006, 28 (1): 219-42. 10.1183/09031936.06.00053805.
Janssen-Heininger YM, Poynter ME, Baeuerle PA: Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med. 2000, 28 (9): 1317-27. 10.1016/S0891-5849(00)00218-5.
Asehnoune K, et al.: Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol. 2004, 172 (4): 2522-9.
Marwick JA, Chung KF, Adcock IM: Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease. Ther Adv Respir Dis. 4 (1): 19-34.
Vanhaesebroeck B, et al.: Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem. 2001, 70: 535-602. 10.1146/annurev.biochem.70.1.535.
Cantley LC: The phosphoinositide 3-kinase pathway. Science. 2002, 296 (5573): 1655-7. 10.1126/science.296.5573.1655.
Venable JD, et al.: Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease. Recent Pat Inflamm Allergy Drug Discov. 2010, 4 (1): 1-15. 10.2174/187221310789895603.
Stoyanov B, et al.: Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science. 1995, 269 (5224): 690-3. 10.1126/science.7624799.
Kok K, et al.: Regulation of p110delta PI 3-kinase gene expression. PLoS One. 2009, 4 (4): e5145.-
Wymann MP, Schneiter R: Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008, 9 (2): 162-76. 10.1038/nrm2335.
Rommel C, Camps M, Ji H: PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nat Rev Immunol. 2007, 7 (3): 191-201. 10.1038/nri2036.
Sadhu C, et al.: Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun. 2003, 308 (4): 764-9. 10.1016/S0006-291X(03)01480-3.
Heit B, et al.: PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat Immunol. 2008, 9 (7): 743-52. 10.1038/ni.1623.
Fukao T, Koyasu S: PI3K and negative regulation of TLR signaling. Trends Immunol. 2003, 24 (7): 358-63. 10.1016/S1471-4906(03)00139-X.
Guha M, Mackman N: The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem. 2002, 277 (35): 32124-32. 10.1074/jbc.M203298200.
Ishii KJ, et al.: Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J Exp Med. 2002, 196 (2): 269-74. 10.1084/jem.20020773.
Ojaniemi M, et al.: Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol. 2003, 33 (3): 597-605. 10.1002/eji.200323376.
Seldon PM, et al.: Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol Pharmacol. 1995, 48 (4): 747-57.
Kirkham PA, et al.: Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med. 2003, 35 (7): 697-710. 10.1016/S0891-5849(03)00390-3.
Liang BT, Galper JB: Differential sensitivity of alpha o and alpha i to ADP-ribosylation by pertussis toxin in the intact cultured embryonic chick ventricular myocyte. Relationship to the role of G proteins in the coupling of muscarinic cholinergic receptors to inhibition of adenylate cyclase activity. Biochem Pharmacol. 1988, 37 (23): 4549-55. 10.1016/0006-2952(88)90671-5.
Weingarten R, et al.: Mastoparan interacts with the carboxyl terminus of the alpha subunit of Gi. J Biol Chem. 1990, 265 (19): 11044-9.
Williams HC, Griendling KK: NADPH oxidase inhibitors: new antihypertensive agents?. J Cardiovasc Pharmacol. 2007, 50 (1): 9-16. 10.1097/FJC.0b013e318063e820.
Triantafilou M, Triantafilou K: Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002, 23 (6): 301-4. 10.1016/S1471-4906(02)02233-0.
Katada T: Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors. Chemistry and physics of lipids. 1999, 98 (1-2): 79.-10.1016/S0009-3084(99)00020-1.
Niwa K, et al.: Redox regulation of PI3K/Akt and p53 in bovine aortic endothelial cells exposed to hydrogen peroxide. Antioxid Redox Signal. 2003, 5 (6): 713-22. 10.1089/152308603770380016.
Nishida M: G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature. 2000, 408 (6811): 492-5. 10.1038/35044120.
Shaw M, Cohen P, Alessi DR: The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J. 1998, 336 (Pt 1): 241-6.